Merck Communicates With UK’s MHRA Over Zocor Switch
This article was originally published in The Tan Sheet
Executive Summary
Escalating discussions in the UK regarding a behind-the-counter switch for Merck's Zocor (simvastatin) may be playing a part in FDA's renewed interest in an OTC switch for Mevacor (lovastatin)in the U.S